Egypt-based on-demand medicine delivery platform has raised a seven-figure (USD) Pre-Series A, without disclosing the exact size of the investment. The money came from 500 Startups (who are following-on), Vision Ventures, Womena and few other investors. Chefaa had previously raised a six-figure seed from 500 Startups, Flat6Labs and a few angel investors in August last year.
“Chefaa is merging ecommerce with the pharmaceutical industry and positioning itself to lead the digital transformation of the pharmaceutical industry. With the capital, we have just raised and support of partners like 500 Startups, Vision Wentures and Womena, we are focused on scaling efficiently and sustainably,” Doaa Aref, the co-founder and CEO of Chefaa, said.
Why The Investors Invested
Hasan Haider, Managing Partner of 500 Startups MENA (500 Falcons), said:
“In the current environment, any startup that can improve people’s lives and assist in social distancing measures is doing a service to all of us. We’re happy to be supporting Chefaa in providing people with a more efficient way to get their medication. The team behind Chefaa have done an exemplary job in executing their goals in a very short period of time, and we look forward to their ongoing success.”
“Health and personal care are basic needs for all humans. Our investment into Chefaa plays a part in ensuring that more people have easy access to basic medicine and personal care products. The team behind Chefaa has shown a deep understanding of the field that translated into great growth. We are glad to be part of their ambitious journey,” Kais Al Essa, Founding Partner & CEO of Vision Ventures said.
Read also: Kenyan Solar Startup d.light Secures $65 Million Debt Funding From Solar Frontier Capital
What The Startup Does
Founded in 2017 by Doaa Aref and Dr. Rasha Rady, Chefaa connects patients and pharmacies, enabling chronic patients to schedule, order, and refill their recurring prescriptions as well as other non-pharmaceutical products from pharmacies, through its web or mobile apps. The Egyptian startup claims to have fulfilled hundreds of thousands of orders to date.
Chefaa, serving as a marketplace, when a customer places an order, routes it to the nearest pharmacy who then delivers the medicines to the customers.
It said in a statement that it is helping tens of thousands of chronic patients across Egypt to properly manage their treatment by enabling them to easily order their medicines on a regular basis. Chefaa focuses on chronic patients with repeat orders but its platform is also open for anyone with a prescription to order their medicines, whenever they need them.
The startup that has recently launched its private and while-label products as well, now plans to use the investment to grow its operations team and launch its B2B service to serve SMEs.
“We take pride in serving our growing base of users as well as managing their pharmacy needs. We have built our customer care center to ensure that user experience is being managed professionally. We also understand the impact of chronic illness as well as chronic patients’ needs and we intend to launch new services all designed around making their lives easier,” Dr. Rasha Rady, the co-founder and COO of the startup, said.
Charles Rapulu Udoh
Charles Rapulu Udoh is a Lagos-based lawyer who has advised startups across Africa on issues such as startup funding (Venture Capital, Debt financing, private equity, angel investing etc), taxation, strategies, etc. He also has special focus on the protection of business or brands’ intellectual property rights ( such as trademark, patent or design) across Africa and other foreign jurisdictions.
He is well versed on issues of ESG (sustainability), media and entertainment law, corporate finance and governance.
He is also an award-winning writer.